CG Oncology CGON Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's other income, net (note 6)?
- CG Oncology (CGON) reported other income, net (note 6) of -$101K in Q1 2026.
- How has CG Oncology's other income, net (note 6) changed year-over-year?
- CG Oncology's other income, net (note 6) decreased by 2120.0% year-over-year, from $5K to -$101K.
- What is the long-term trend for CG Oncology's other income, net (note 6)?
- Over 2 years (2023 to 2025), CG Oncology's other income, net (note 6) has grown at a 56.6% compound annual growth rate (CAGR), from -$62K to -$152K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.